Hereditary Breast and Gynecologic Cancers Panel
A 21-gene panel for assessing hereditary risk for breast, ovarian, and uterine cancers, powered by the Helix Exome+® platform for comprehensive variant detection.
6-21 days
≤ 5 days
Panel Description
Hereditary predisposition to breast and gynecologic cancer refers to the increased likelihood of developing adult-onset uterine and ovarian cancer in addition to breast cancer. The most well-known genes are BRCA1 and BRCA2 and those associated with Lynch syndrome, although there are others, including the genes on this panel. Individuals with a pathogenic variant may also have an increased risk of other cancers such as colorectal and prostate, depending on the affected gene.
This panel evaluates 21 genes that have an established, primary association with hereditary breast and/or gynecologic cancers (ovarian and uterine).
Have Questions?
Our team is available Monday through Friday, 9am-5pm Pacific Time.
Indications for Testing
A personal and/or family history suggestive of a hereditary form of breast and gynecologic cancers (ovarian and uterine).
Methodology
This test utilizes next-generation sequencing to detect single nucleotide variants, insertions and deletions up to 20 bp, and copy number variants in genes associated with hereditary forms of breast and gynecological cancer.
Technical Specifications
> 99%
> 99%
> 99%
> 99%
> 90%
BRCA1: sequencing analysis extends to CDS +/-20 bp; BRCA2: analysis includes detection of c.156_157insAlu and sequencing analysis extends to CDS +/-20 bp; EPCAM: analysis is limited to CNV of exons 8-...
GRCh38
Genes Tested
Showing 21 of 21 genes in this panel